glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results and Survival Benefits of in Diabetes With Chronic Kidney Disease: Cardiovascular Subgroup Analyses FLOW trial Ozempic® (semaglutide injection)

Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: a review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials

GLP-1RAs (including liraglutide and exenatide) prove to be beneficial in improving mitochondrial dynamics, increasing mitochondrial biogenesis, and preventing mitochondrial fragmentation [96]

Clinicians can and do prescribe it off-label for weight loss, but insurance coverage and access differ between Mounjaro and Zepbound depending on your plan and diagnosis

GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar

The best weight-loss medication for you can only be determined by your healthcare provider, who will evaluate your individual medical conditions and history